Vimarsana
Biggest News Aggregation in the World

Page 9 - Integrative Screening Process News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Integrative Screening Process. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Integrative Screening Process Today - Breaking & Trending Today

Ipsen : and IRLAB enter exclusive worldwide licensing agreement aimed to improve the lives of people living with Parkinson's disease -Today at 11:02 am - Vimarsana News

Ipsen : and IRLAB enter exclusive worldwide licensing agreement aimed to improve the lives of people living with Parkinson's disease -Today at 11:02 am

Ipsen obtains the exclusive worldwide rights to develop and commercialize the investigational treatment mesdopetam which is based on a novel mechanism of action ...

IRLAB Secures Full Ownership of the Mesdopetam Project and Continues ... - Vimarsana News

IRLAB Secures Full Ownership of the Mesdopetam Project and Continues ...

IRLAB Secures Full Ownership of the Mesdopetam Project and Continues ...

IRLAB's Phase IIb Study with Pirepemat Passes DSMB Safety Review with Unanimous Recommendation to Continue the Ongoing Phase IIb Study - Vimarsana News

IRLAB's Phase IIb Study with Pirepemat Passes DSMB Safety Review with Unanimous Recommendation to Continue the Ongoing Phase IIb Study

17.07.2023 - GOTHENBURG, SWEDEN / ACCESSWIRE / July 17, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, July 17, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's ...

IRLAB to Present Data from the Phase IIb Study of Mesdopetam in PD-LIDs at the MDS Congress 2023 - Vimarsana News

IRLAB to Present Data from the Phase IIb Study of Mesdopetam in PD-LIDs at the MDS Congress 2023

20.06.2023 - GOTHENBURG, SE / ACCESSWIRE / June 20, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, June 20, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's ...

IRLAB to Present Data from the Phase IIb Study of Mesdopetam in PD-LIDs ... - Vimarsana News

IRLAB to Present Data from the Phase IIb Study of Mesdopetam in PD-LIDs ...

IRLAB to Present Data from the Phase IIb Study of Mesdopetam in PD-LIDs ...